# Effect of Atogepant for Preventive Migraine Treatment on Patient-Reported Outcomes in the Randomized, Double-blind, Phase 3 ADVANCE Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effect-of-atogepant-for-preventive-migraine-treatment-on-patient-reported/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Richard B. Lipton,Patricia Pozo‐Rosich,Andrew Blumenfeld,Ye Li,Lawrence Severt,Jonathan Stokes,Lela Creutz,Pranav Gandhi,David W. Dodick |
| Citations | 31 |
| DOI | 10.1212/wnl.0000000000201568 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://n.neurology.org/content/neurology/early/2022/11/17/WNL.0000000000201568.full.pdf |
| OpenAlex ID | https://openalex.org/W4309263777 |
| PMID | 36396451 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Pranav Gandhi](https://scholariq.org/researchers/pranav-gandhi/)

## Paper journal

- [Neurology](https://scholariq.org/journals/neurology/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Traumatic Brain Injury Research](https://scholariq.org/topics/traumatic-brain-injury-research/)
- [Nicotinic Acetylcholine Receptors Study](https://scholariq.org/topics/nicotinic-acetylcholine-receptors-study/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.